• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

Introduction to (6-(Trifluoromethoxy)pyridin-3-yl)methanol (CAS No. 1361825-40-2)

(6-(Trifluoromethoxy)pyridin-3-yl)methanol, with the CAS number 1361825-40-2, is a significant compound in the field of pharmaceutical and chemical research. This compound belongs to the pyridine derivative family, characterized by its unique structural and functional properties. The presence of a trifluoromethoxy group and a hydroxymethyl moiety makes it a versatile intermediate in the synthesis of various bioactive molecules.

The trifluoromethoxy group is particularly noteworthy due to its ability to influence the electronic properties of the molecule, making it valuable in medicinal chemistry for designing compounds with enhanced metabolic stability and improved binding affinity to biological targets. Recent studies have highlighted the role of trifluoromethyl-containing compounds in developing drugs with better pharmacokinetic profiles. For instance, the incorporation of this group has been shown to increase lipophilicity and reduce susceptibility to enzymatic degradation, which are critical factors in drug design.

In addition to its structural significance, (6-(Trifluoromethoxy)pyridin-3-yl)methanol has been explored in various synthetic pathways. Its methanol side chain provides a reactive site for further functionalization, enabling the creation of more complex molecules. Researchers have utilized this compound as a building block in the synthesis of kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The pyridine core is particularly important in these applications due to its ability to interact with metal ions and other small molecules, facilitating the development of targeted therapies.

Recent advancements in computational chemistry have further enhanced the understanding of (6-(Trifluoromethoxy)pyridin-3-yl)methanol's reactivity and potential applications. Molecular modeling studies have revealed that the compound can form stable complexes with certain enzymes, suggesting its utility in developing novel inhibitors. These findings are particularly relevant in the context of drug discovery, where identifying new binding sites and interaction modes is essential for overcoming resistance mechanisms.

The pharmaceutical industry has also shown interest in this compound due to its potential as a precursor for antiviral and antibacterial agents. The trifluoromethoxy group's electron-withdrawing nature can modulate the reactivity of adjacent functional groups, making it possible to design molecules with specific biological activities. For example, modifications at the 3-position of the pyridine ring have been investigated for their effects on antiviral potency. Such studies contribute to the growing body of evidence supporting the use of pyridine derivatives in addressing emerging infectious diseases.

Moreover, (6-(Trifluoromethoxy)pyridin-3-yl)methanol has found applications in materials science, particularly in the development of organic electronic materials. The combination of electron-withdrawing and donating groups within its structure allows for tuning its electronic properties, making it suitable for use in organic semiconductors and light-emitting diodes (OLEDs). These applications are part of a broader trend toward using tailored molecular architectures to enhance performance in electronic devices.

The synthesis of (6-(Trifluoromethoxy)pyridin-3-yl)methanol involves multi-step reactions that require precise control over reaction conditions. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity. These methods are essential for producing compounds that meet the stringent requirements of pharmaceutical applications. The growing interest in green chemistry has also influenced synthetic approaches, with efforts focused on reducing waste and improving atom economy.

In conclusion, (6-(Trifluoromethoxy)pyridin-3-yl)methanol (CAS No. 1361825-40-2) is a multifaceted compound with significant potential across multiple domains of chemistry and biology. Its unique structural features make it a valuable intermediate in drug discovery, materials science, and other areas requiring tailored molecular functionality. As research continues to uncover new applications for this compound, its importance is likely to grow further, contributing to advancements in medicine and technology.

• 1198103-42-2(6-(Difluoromethoxy)nicotinonitrile)
• 1211535-62-4(6-(difluoromethoxy)pyridine-3-carboxylic acid)
• 1214323-29-1(2-(Difluoromethoxy)-5-phenylpyridine)
• 2222104-49-4((2-(Difluoromethoxy)pyridin-3-yl)methanol)
• 1211584-72-3(5-(Bromomethyl)-2-(trifluoromethoxy)pyridine)
• 1375098-07-9((6-(Difluoromethoxy)pyridin-3-yl)methanol)
• 1268516-11-5((2-(Difluoromethoxy)pyridin-4-yl)methanol)
• 1261728-42-0(2-(Difluoromethoxy)-5-(4-(trifluoromethoxy)phenyl)pyridine)
• 1361849-85-5(6-(trifluoromethoxy)pyridine-3-carbaldehyde)
• 940895-85-2(6-(trifluoromethoxy)pyridine-3-carboxylic acid)